In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells.
about
Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasiaAssociation of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancerhrHPV E5 oncoprotein: immune evasion and related immunotherapies.Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironmentPrevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus.High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.Persistence of human papillomavirus infection: keys to malignant progressionMolecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion DevelopmentEpstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies.Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control studyThe SNP at -592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development.Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesionsThe relationship between the antitumor effect of the IL-12 gene therapy and the expression of Th1 cytokines in an HPV16-positive murine tumor model.The human papillomavirus E7 oncoprotein as a regulator of transcription.Novel Approaches for Vaccination Against HPV-Induced Cancers.PTEN functions as a melanoma tumor suppressor by promoting host immune response.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.TGF-β1 genetic variants predict clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.[HPV-associated squamous cell carcinogenesis].Cervical cancer-associated promoter polymorphism affects akna expression levels.Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas.
P2860
Q27010447-B51E5B58-D8C5-4872-B95E-4F3D7297A3B7Q33699084-594AE325-C067-47F7-889B-13313C753247Q33730462-E974384D-E15A-46AE-B789-F64312C3C035Q34052237-FAD8364B-BC61-43FB-8E7C-96EF616B7EEDQ34159707-827119E6-B63A-4EB3-AE20-91C1CA71681FQ34256122-B4674305-C45F-4871-ABE5-12B9F34F4A67Q34480019-AE0DE25B-A343-4257-8312-1A354B49CA2DQ34690139-A12A671D-BCC9-4D4C-BC2A-E532B0831E6FQ35636308-9A8C48FA-84B9-4BAF-A5D7-FA31D4D69BCEQ35777091-15338EA4-F47C-4173-83FC-9BFA7A616095Q35962518-4B6A476B-B053-4D39-968F-66DD5867AEB5Q35999306-3122B41F-1AE6-47B8-9B2A-0BF6D6360B8EQ36028161-FE47DAD1-A3C4-41F2-95B9-EC8602A05CABQ36555779-D3B91F12-71AE-40EE-9E12-2AFB49655131Q37135023-49794151-8A59-4774-9E2D-ECDC54B530ECQ37367538-AB1C93F8-BD05-413E-85EB-F2050DBDFF32Q37511930-AF1E212C-160B-4965-BCF0-9AF265F45AC1Q37720469-BEB78EED-6F7E-4D9A-9D2D-555D8D1F9B9DQ39000409-CA31CC5A-EA4C-48A2-BCD6-DFB9CAA0E524Q39033362-60E0AB33-4B41-497A-B1F0-F8045C894E10Q39076276-3A3CB259-E31E-49C1-8FB8-364234728B18Q40444191-061DE3C2-D89F-45BD-B60C-161F906A6FD3Q49791863-9C7EDDC6-E0A9-4580-9AEA-56652F80F069Q50087551-AF1E94CE-85A8-4F2B-A81A-B35FEA836CEEQ53218060-34A89B8E-4AE9-48C9-984A-3A3F2E72366CQ53749377-1757FB41-F427-42AB-B812-EA5689788AC7Q54515558-58BCB3DD-5010-4C44-9E5A-72C85A37BC11Q55003290-C0FBAED8-D0BC-421D-BC39-ABCB1D4BFE0FQ55463659-FD6E7082-4457-4C9E-B8D7-684B655C6378
P2860
In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In vivo expression of immunosu ...... sformed cervical cancer cells.
@en
type
label
In vivo expression of immunosu ...... sformed cervical cancer cells.
@en
prefLabel
In vivo expression of immunosu ...... sformed cervical cancer cells.
@en
P2093
P356
P1433
P1476
In vivo expression of immunosu ...... sformed cervical cancer cells.
@en
P2093
Jaime Berumen
José Moreno
Juan Manuel Alcocer-González
Oscar Peralta-Zaragoza
Patricio Gariglio
Reyes Taméz-Guerra
Rogelio Hernández-Pando
Vicente Madrid-Marina
Víctor Bermúdez-Morales
P304
P356
10.1089/VIM.2006.19.481
P577
2006-01-01T00:00:00Z